Mercè Obach (Obach Mercè, Mercè Obach Cortadellas)

Publication Activity (10 Years)

Years Active: 2021-2022
Publications (10 Years): 3

Top Topics

Transcription Factor

Clinical Evaluation

Papillary Thyroid

Top Venues

BMC health services research

Expert review of pharmacoeconomics & outcomes research

Expert opinion on biological therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Iglesias-Lopez Carolina, Antònia Agustí, Mercè Obach, Vallano Antonio
Regulatory and clinical development to support the approval of advanced therapies medicinal products in Japan. Expert opinion on biological therapy 22 (7) (2022)
David Elvira, Mercè Obach, Caridad Pontes
Description of the use of multicriteria to support pricing and reimbursement decisions by European health technology assessment bodies. BMC health services research 21 (1) (2021)
Brian B Godman, Andrew Hill, Steven R A Simoens, Gisbert W Selke, Iva Selke Krulichová, Carolina Zampirolli Dias, Antony Paul Martin, Wija Oortwijn, Angela Timoney, Lars L Gustafsson, Luka Voncina, Hye-Young Kwon, Jolanta Gulbinovic, Dzintars Gotham, Janet Wale, Wânia Cristina da Silva, Tomasz Bochenek, Eleonora Allocati, Amanj Baker Kurdi, Olanyika O Ogunleye, Johanna Catharina Meyer, Iris Hoxha, Admir Malaj, Christian Hierländer, Robert Sauermann, Wouter Hamelinck, Guenka Petrova, Ott Laius, Irene Langner, John N Yfantopoulos, Roberta Joppi, Arianit Jakupi, Ieva Greiciute-Kuprijanov, Patricia Vella Bonanno, Jf Hans Piepenbrink, Vincent de Valk, Magdalene Wladysiuk, Vanda Marković-Peković, Ileana Mardare, Jurij Fürst, Dominik Tomek, Mercè Obach, Corinne Zara Yahni, Caridad Pontes, Stuart McTaggart, Tracey-Lea Laba, Øyvind Melien, Durhane Wong-Rieger, Seung Jin Bae, Ruaraidh A Hill
Potential approaches for the pricing of cancer medicines across Europe to enhance the sustainability of healthcare systems and the implications. Expert review of pharmacoeconomics & outcomes research 21 (4) (2021)